Abstract
HIV-1 gp120 protein has been shown to promote mesangial cell (MC) injury. Scatter factor (SF) is a growth factor that plays a reparative role in various experimental models of renal lesions. We hypothesize that SF protects MC against HIV-1 gp120-induced MC injury. gp120 at a low dose, stimulated HMC proliferation (p < 0.0001). SF (50 ng/ml) further enhanced low-dose gp120-induced HMC proliferation. However, gp120 at higher doses (10–100 ng/ml) promoted HMC apoptosis. Nevertheless, SF attenuated the high-dose gp120-induced HMC apoptosis. Interestingly, gp120 at a low dose not only induced NF-ĸB activation but also increased p21cip1/waf1 andp27kip1 protein levels.
Journal Section:
Original Paper
References
1.
Rao TK, Fillipone EJ, Nicastri AD: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:669–673.
[PubMed]
2.
D’Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 1997;8:138–152.
[PubMed]
3.
Michael AF, Keane WF, Raij L, Vernier RL, Mauer SM: The glomerular mesangium Kidney Int 1980;17:141–154.
4.
Pesce CM, Striker U, Peter E, Elliot S, Striker GE: Glomerulosclerosis at both early and late stage is associated with cell turnover in mice transgenic for growth hormone. Lab Invest 1991;65:601–605.
[PubMed]
5.
Floege J, Burns MW, Alpers CF, Yoshimura A, Pritzel P, Gordon K, Seifert R, Brown-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and matrix synthesis. Kidney Int 1992;41:297–309.
[PubMed]
6.
Bodi I, Andrew A, Kimmel PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 1995;26:286–291.
[PubMed]
7.
Kapasi AA, Fan S, Singhal PC: Role of 14-3-3υ, c-Myc/Max, and Akt phosphorylation in HIV-1 gp120-induced mesangial cell proliferation. Am J Physiol 2001;280:F333–F342.
8.
Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker IC, Manca F: AIDS pathogenesis: HIV envelop protein and its interaction with cell proteins. Immunol Today 1990;11:418–425.
[PubMed]
9.
Singhal PC, Sharma P, Franki N, Reddy K, Sanwal V, Gibbons N: HIV-1 gp160 protein modulates mesangial cell proliferation and apoptosis. Nephron 1997;76:284–295.
[PubMed]
10.
Singhal PC, Sharma P, Singhal M, Kapasi A, Gibbons N: HIV-1 gp160 protein modulates proximal tubular cell proliferation and matrix synthesis. Cell Physiol Biochem 1997;7:43–52.
11.
Bardelli A, Longatti P, Albero S, Goruppi C, Schneider C, Pnzetto C, Comoglio PM: HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 1996;15:6205–6212.
[PubMed]
12.
Frisch SM, Francis H: Disruption of epithelial cell cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619–626.
[PubMed]
13.
Fan S, Ma YX, Wang J, Yuan R, Meng Q, Cao Y, Laterra J, Goldberg I, Rosen EM: The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidylinositol 3′ kinase. Oncogene 2000;19:2212–2223.
[PubMed]
14.
Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg I, Rosen EM: The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol 2001;21:4968–4984.
[PubMed]
15.
Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987;327:238–242.
16.
Collins I, Garrett MD: Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Curr Opin Pharmacol 2005;5:366–373.
[PubMed]
17.
Sengul S, Zwinzinski C, Simon E, Kapasi A, Singhal PC: Endocytosis of light chain induces cytokine through activation of NF-κB in human proximal tubular cells. Kidney Int 2002;62:1977–1988.
[PubMed]
18.
Chander P, Soni A, Suri A, Bhagwat R, Yoo J, Treser G: Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 1987;126:513–526.
[PubMed]
19.
Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Echhaus M, Dicki P, Marinos NJ, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced basement membrane components in mice transgenic for HIV-1 genes. Proc Natl Acad Sci USA 1992;89:1577–1581.
[PubMed]
20.
Dicki P, Felser J, Echhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991;185:109–119.
[PubMed]
21.
Liu Y: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002;11:23–30.
[PubMed]
22.
Fornoni A, Li H, Foschi A, Striker GE, Striker LJ: Hepatocyte growth factor, but not insulin-like growth factor-1, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 2001;158:275–280.
[PubMed]
23.
Kitta K, Day RM, Ikeda T, Suzuki YJ: Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 2001;31:902–910.
[PubMed]
24.
Liu Y, Sun AM, Dworkin LD: Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 1996;246:821–826.
[PubMed]
25.
Yo Y, Morishita R, Ogihara T, et al: Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int 1998;54:1128–1138.
[PubMed]
26.
Lohr JW, Lee TP, Farooqui M, Mookerjee BK: Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J Med 2000;31:131–141.
[PubMed]
27.
Mizuno S, Matsumoto K, Nakamura T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2001;59:1304–1314.
[PubMed]
28.
Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM: Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 2005;24:1749–1766.
[PubMed]
© 2006 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2006
You do not currently have access to this content.
